Susannah Stanway qualified from Bristol University in 1998 and subsequently obtained an MD thesis for her work on Steroid Sulphatase Inhibition in postmenopausal patients with Breast Cancer from Imperial College in 2009. Her oncology training was undertaken at UCLH and Royal Marsden Hospital (RMH), UK. She completed an MSc thesis for her work on risk stratification to guide follow up after childhood malignancy. She worked at consultant level between 2012 and 2020 at the RMH London UK and had an associate honorary faculty position at the Institute of Cancer Research (ICR). In 2018 she was made a Fellow of the Royal College of Physicians. She is a past president of the Oncology Section at the Royal Society of Medicine.

Dr Stanway’s principle research and education interests centre around cancer control in low-middle income countries (LMICs). She sits on the editorial board of ASCO’s Journal of Global Oncology and leads a sub-module on Cancer in Low-Middle Income Countries on the ICR’s MSc course. She has actively contributed to oncology education of junior doctors by facilitating ‘train the trainers courses’ in East Africa a partnership between the East African Development Bank, the British LMICs’ conference held annually at the Royal Society of Medicine since 2016 which in 2019 became the annual London Global Cancer Week (https://www.lgcw.org.uk) with multiple meetings and events involving international groups involved in cancer care such as the UN agencies, The Commonwealth, the Lancet Oncology and Chatham House, London. She has received awards from the Global Challenges Research Fund to study unmet needs in women following breast cancer treatment in Ghana and Tanzania and to help develop palliative care services in the Democratic Republic of the Congo. She is the founder and co-chair of the RMH/ICR Cancer Control in LMICs Collaborative Group focusing on collaborative research and education in low resource settings within the two institutions.  She has co-led the establishment of the UK Global Cancer Network.

Susie has also been actively involved in research and education around cancer survivorship. This includes the area of cardio-oncology, in collaboration with amongst others, the Cardio-Oncology Group at the Royal Brompton Hospital and the London School of Hygiene and Tropical Medicine (where she has recently co-supervised a PhD student); treatment-induced Hot Flushes (where she sits on the NCRI Symptom Management Working Group); In 2017 she co-chaired the Global Cardio-Oncology Summit in London and in 2020 she spoke at the Global Cardio-Oncology Summit; she also has interests in sexual and psychological consequences of cancer. She has historically co-chaired the RMH’s Living With and Beyond Cancer Committee, sat on the RM Partners Vanguard Survivorship Pathway and set up and co-chaired a pan London Survivorship Research Group; She has an interest in digital tools for cancer patients and has co-led an early phase clinical trial evaluating a mobile phone app to help patients manage side effects on oral chemotherapy and also has participated in research on digital tools for patients to better navigate the cancer pathway.

She speaks locally, nationally, and internationally and has published in peer-reviewed journals.

She is a member of the American Society of Clinical Oncology, the Royal Society of Medicine, the British Breast Group, the Association of Cancer Physicians, British Cardio-oncology Society, and British Medical Association and is a Fellow of the Royal College of Physicians. She is an ESMO member and a member of the ESMO Global Policy Committee.